|
|
| MRD / Regn No. |
: 7946 |
Date |
: 23/07/2026 |
| Patient Name |
: Shristidhar Das |
Age & Gender |
: 43 Yrs. / Male |
| Contact No. |
: 7003367240 |
UHID |
: |
| Ht / Wt / BMI |
: 171 / 68 / 23.26 |
BP S / BP D |
: 97 / 60 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (30/Nov/2021) | RENAL TRANSPLANT: 2016 (30/Nov/2022) | |
|
Plan |
: |
OTHER MEDICINES ACCORDING TO NEPHROLOGISTS |
|
| Salient Investigations |
: |
CREATININE: 1.3 | EGFR EGLOMERULAR FILTRATION RATE: 64.16 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 179 mg/dL | HB HEMOGLOBIN: 15.9 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 10.2 % | LDL LOW DENSITY LIPOPROTEIN: 160 mg/dL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
2 |
ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 23/Sep/2026 |
| Tests Suggested For Next Visit |
: FPG,PPG |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |